Skip to content

Reading Together: How to Promote Children's Language Development Using Family-based Shared Book Reading

Reading Together: How to Promote Children's Language Development Using Family-based Shared Book Reading

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02625584
Enrollment
150
Registered
2015-12-09
Start date
2016-01-31
Completion date
2018-04-30
Last updated
2018-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Language Development

Keywords

Shared Book Reading, Dialogic Reading, Language Development, Syntax, Vocabulary, Young Children, Randomised Control Trial, Language Intervention

Brief summary

The aim of this project is to determine how shared reading promotes child language development, and to use this knowledge to make it an effective language-boosting tool for children from all social and economic backgrounds.

Detailed description

Two interventions will be created which are intended to boost children's vocabulary and grammar abilities, and will be assessed on how they are implemented by caregivers across different socio economic groups, and how they affect children's development of these language skills. Previous research has found dialogic reading interventions to be less effective for children from low socio-economic backgrounds. This project will investigate whether a shared reading intervention, designed to require less of a behaviour change from caregivers than dialogic reading, can be used to effectively boost vocabulary and grammar development in children across the whole socio-economic spectrum.

Interventions

BEHAVIORALReading Together - Pausing for Reading
BEHAVIORALReading Together - Dialogic Reading
BEHAVIORALReading Together - Shared Reading Control

Sponsors

Caroline Rowland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Months to 36 Months
Healthy volunteers
Yes

Inclusion criteria

* All families will be included unless they fit the

Exclusion criteria

.

Design outcomes

Primary

MeasureTime frameDescription
Change in baseline language skills (PLS-5)Baseline and 6 weeksThe Preschool Language Scale Fifth Edition (PLS-5) Will be administered. This is a published standardized measure of the language knowledge of individual children. The investigators will use both the Auditory Comprehension and Expressive Communication scales to measure vocabulary and grammar knowledge. The PLS-5 standard scores are based on a mean of 100 with a standard deviation of 15. Scores between 85 and 115 are considered to be within the normal range.

Secondary

MeasureTime frameDescription
Change in baseline syntax comprehension (CELF Preschool-2 UK)Baseline and 6 weeksThe Clinical Evaluation of Language Fundamentals - Preschool 2 UK (CELF Preschool-2) will be administered. This is a published standardized measure of the language knowledge of individual children. The investigators will use the 'Sentence Structure' subtest. This will allow measurement of the children's understanding of a range of simple and complex sentence structures. A sentence is read to the child and the child chooses, from a set of pictures, which picture ''goes with'' that sentence.
Change in baseline caregiver dialogic reading behaviourBaseline and 6 weeks10 minute video recordings of the dyads reading books at baseline and 6 weeks will be analysed for the number of target dialogic reading behaviours. This will allow measurement of the caregiver's dialogic reading behaviour pre- and post-intervention.
Change in baseline caregiver pause reading behaviourBaseline and 6 weeks10 minute video recordings of the dyads reading books at baseline and 6 weeks will be analysed for the number of target pause reading behaviours. This will allow measurement of the caregiver's pause reading behaviour pre- and post-intervention.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026